At the molecular level, the research proposes that GHK-Cu may interact with the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-B) signaling pathway
Drug treatment
KLOW differs from GLOW in component count (4 vs 3), dominant component (BPC-157 vs GHK-Cu), total mass (80mg vs 70mg), and primary research application (joint/soft-tissue recovery vs dermal/cosmetic)
Colchicine (Colcrys, Mitigare): using the matches analogy discussed above1, using colchicine can be seen as dampening the uric acid matches. Colchicine does not lower the bodys store of uric acid, but it decreases the intensity of the bodys inflammatory reaction to these crystals
Ameliorating effect of vitamin E on in vitro development of preimplantation buffalo embryos
GHK acts like a delivery truck, carrying copper to the exact cells that use it, then signaling those cells to start rebuilding